Retraction: Receptor Tyrosine Kinase Inhibitor Sunitinib And Integrin Antagonist Peptide Hm-3 Show Similar Lipid Raft Dependent Biphasic Regulation Of Tumor Angiogenesis And Metastasis (Retraction Of Vol 38, Art No 381, 2019)

The authors have retracted this article [1] because the bands shown in Fig. 5 panel D for GTP-RhoA/Control, GTP-RhoA/Sunitinib (2 and 64nM) and GTP-RhoA/HM-3 (4.5 and 72 uM) are not data generated as part of this study. All authors agree to this retraction.